Pancreatic Cancer Research

ResearcherSixth Affiliated Hospital of Sun Yat-sen UniversityActive in the last 2 years

Mong-Hong Lee

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0001-8675-8215; OpenAlex author ID A5017186474.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 2)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. CSN6 Promotes Pancreatic Cancer Progression and Gemcitabine Resistance via Antagonizing DCAF1-Mediated Ubiquitination of NPM1. Last author DOI 10.1002/advs.202510210↗
  2. Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth. Last author DOI 10.1093/gastro/goaa018↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Yijing Zhang · 1 shared paper, 2026
  2. Guermarie Velázquez-Torres · 1 shared paper, 2020

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.